Welcome to Generic Pharmacist Website

viagra generic

Viagra generic pill producers have seen several things go there way, as the internet has allowed a rapid dispersal of information on the number of Viagra generic alternatives. This has been made available through word of mouth on internet forums and through e-drugstores.

In several legal battles, producer of Viagra has lost the right to patent the active chemical Sildenafil Citrate in much of Europe. This has all but allowed an open market in the Viagra generic sales. While much of the success of pharmaceutical companies have been in the retention of patent rights, the willingness of rival pharmaceutical companies Eli Lilly and Co. and ICOS Corp to engage in large legal actions have given the Viagra generic producers a chance to compete in the multi billion dollar per annum industry.

The loss of patent rights in one region has allowed those that purchase on the internet to make exploit divergent international laws. Pfizer retains its patent on the drug until 2013, but loses the exclusive use of Sildenafil Citrate. This effectively ends the patent on Viagra in Britain.

Viagra generic alternatives are becoming attractive to consumers. The Viagra generic pills are produced globally in countries such as India, Belize and other technologically advanced nations who benefit from undervalued currencies. This allows them to cut costs with their Viagra generic pills. Caverta, Veega are but two of the Indian Viagra generic pills produced.

The safety of global pharmaceutical production has made health concerns about Viagra generic pills largely rhetoric to support the high prices charges by Viagra in the U.S. market. The Viagra generic market conforms to the World Trade Organizations guidelines on safety. Doubts about safety of Viagra generic varieties can also be countered by the Food and Drug Administrations own approval of many of the offerings. They Viagra generics fit the FDA’s mandate that they are the same “in dosage form, safety, strength, route of administration, quality, performance characteristics and intended use.”

The Viagra generic market is unusual, in that many of the firms producing Viagra generic pills are major manufacturers. Usually the production of generic drugs occurs in the developing world, made by smaller companies.

Consumers desire to purchase the Viagra generics which have previously been unavailable because of Pzifer’s patent. Even U.S. President George W. Bush has promised to open the generic market further. The move would provide cheap access to medication.

Viagra generic producers have typically not spent as much on advertising that Pfizer has. The informed consumer benefits from this absence, enjoying savings on Viagra generic sales of Sildenafil Citrate.

Typically, the sales of Viagra have been 60% more than the cost of Viagra generic varieties. This is typical of the pharmaceutical industry, and Viagra generic pills benefit from their entrance into a grossly inflated market maintained through heavy lobbying by the Pharmaceutical Research and Manufacturers of America (PhRMA), the industry trade group.

Through online purchasing, many are to take advantage of inexpensive Viagra generic pharmaceuticals. The online e-drugstore has made deals on Viagra easier to find. The widely used Viagra generic products offer a great savings as internet retailers compete in a global marketplace. The ability to buy and sell in volume has allowed for great deals on Viagra generic pills.

The FDA reports that although generic drugs are chemically identical, their purchase saves $8 to $10 billion dollars a year for consumers. Online savings can be even greater as many online pharmacies take advantage of global producers of Viagra generic pills.

While Pfizer may claim that Viagra is different than the Viagra generic varieties, they all share the active medical ingredient Sildenafil Citrate. This is the active component of Viagra and the chemical originally patented by Pfizer under the Viagra trademark. With as many as half of men experiencing Erectile Dysfunction (ED) in their middle ages, the marketing of Viagra generic products will keep the market very competitive.

The effectiveness of Sildenafil Citrate (Viagra generic) has been proven in a 6 month study to help sexual function in 88% of men treated increasing the amount of sexual activity with increased satisfaction both in sexual intercourse and their relationship with their partner. With such results, Viagra generic varieties look to take over the market for sexual dysfunction, appealing to the intelligent consumer.